-
Study aim
-
Safety assessment of I-Tech Prostheses in Patients with Knee Osteoarthritis
-
Design
-
phase one clinical trial without control group on 15 patients
-
Settings and conduct
-
In this Phase-1 Clinical Trial, 15 patients with osteoarthritis who are candidates for total knee replacement surgery at Shafa Yahyaian Hospital will be enrolled in the study. Thus, 15 patients with osteoarthritis of the knee who are on the knee replacement surgery list will be enrolled in the study after the clinical plan is explained by colleagues and informed consent is obtained, and they will be followed up for 12 months.
-
Participants/Inclusion and exclusion criteria
-
Patients with knee osteoarthritis grade 3 or 4 K-L, both genders, age between 45-65 years.
-
Intervention groups
-
Patients with knee osteoarthritis grade 3 or 4 K-L who underwent TKA with I-Tech prosthesis Iranian company
-
Main outcome variables
-
Patients will be followed for 12 months for infection, range of motion, pain, function, and quality of life. Follow-ups will be based on clinical assessment of pain reduction (KSS: Knee society score, VAS: Visual analog scale, WOMAC: Western Ontario and McMaster Universities Osteoarthritis Score, Kujala Anterior Knee Pain Scale), overall joint function, patient walking distance, and imaging findings (X-ray) at specific times (4 weeks, 3 months, 6 months, and 12 months after surgery).